Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CTEC: Cholestech any other investors? -- Ignore unavailable to you. Want to Upgrade?

To: epicure who wrote (403)	1/9/1998 4:58:00 PM
From: John Kratus	Read Replies (2) \| Respond to of 710

I called the company in Toronto to get the scoop about the cholesterol test. Nobody from investor relations was in, but I was told that someone will call me Monday morning. I'll pass along whatever I learn. John

To: epicure who wrote (403)	1/12/1998 2:27:00 PM
From: David Martin	Read Replies (1) \| Respond to of 710

The cholesterol test measures cholesterol bound to the layers of the skin. A skin test, if successful at clinicals, would eliminate the pain of a fingerprick and the variability (i.e. day to day or diet related) associated with blood cholesterol testing. The clinical study is to determine the correlation between skin cholesterol and the components of blood cholesterol (total cholesterol, VLDL, LDL, and HDL fractions) and the correlation directly between skin chol. and heart disease. Yes they would apply for a CLIA waiver assuming the clinicals went well and they received FDA approval. In some ways its not disimilar to Chemtrak or Cholestech. The ultimate use for the cholesterol test could be in a physicians office or over-the-counter sales at a pharmacy, or large scale screening programs.